Reccurent guillain barré syndrome after COVID-19

Authors

• Svetlana D. Miletic Drakulic
• Snezana R. Lazarevic
• Ivana P. Miloradovic
• Vladimir S. Jankovic

Abstract

Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2–6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2–6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.

Article Type

Case Report

First Page

273

Last Page

276

Recommended Citation

Drakulic, Svetlana D. Miletic; Lazarevic, Snezana R.; Miloradovic, Ivana P.; and Jankovic, Vladimir S. (2023) "Reccurent guillain barré syndrome after COVID-19," Neurosciences: Vol. 28: Iss. 4, Article 10.
DOI: https://doi.org/10.17712/nsj.2023.4.20230012